Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.
Saved in:
| Title: | Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease. |
|---|---|
| Authors: | Ray GL; Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; x_ray82@hotmail.com (G.L.R.); baidook@mail.nih.gov (K.E.B.); lkeller8@hotmail.com (L.M.M.K.); martinwb@mail.nih.gov (M.W.B.)., Baidoo KE, Keller LM, Albert PS, Brechbiel MW, Milenic DE |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2011 Dec 22; Vol. 5 (1), pp. 1-15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Print Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 22229017 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ray+GL%22">Ray GL</searchLink>; Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; x&#95;ray82@hotmail.com (G.L.R.); baidook@mail.nih.gov (K.E.B.); lkeller8@hotmail.com (L.M.M.K.); martinwb@mail.nih.gov (M.W.B.).<br /><searchLink fieldCode="AU" term="%22Baidoo+KE%22">Baidoo KE</searchLink><br /><searchLink fieldCode="AU" term="%22Keller+LM%22">Keller LM</searchLink><br /><searchLink fieldCode="AU" term="%22Albert+PS%22">Albert PS</searchLink><br /><searchLink fieldCode="AU" term="%22Brechbiel+MW%22">Brechbiel MW</searchLink><br /><searchLink fieldCode="AU" term="%22Milenic+DE%22">Milenic DE</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2011 Dec 22; Vol. 5 (1), pp. 1-15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22229017 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph5010001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ray GL – PersonEntity: Name: NameFull: Baidoo KE – PersonEntity: Name: NameFull: Keller LM – PersonEntity: Name: NameFull: Albert PS – PersonEntity: Name: NameFull: Brechbiel MW – PersonEntity: Name: NameFull: Milenic DE IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 12 Text: 2011 Dec 22 Type: published Y: 2011 Identifiers: – Type: issn-print Value: 1424-8247 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: Pharmaceuticals (Basel, Switzerland) Type: main |
| ResultId | 1 |
